The forecasted data for hospital discharges due to malignant neoplasm of the trachea, bronchus, and lung in Italy from 2024 to 2028 indicates a consistent year-on-year decline. In 2024, the number of discharges is expected to be 38.31 thousand, decreasing annually to 34.73 thousand by 2028. Compared to 2023, this suggests a steady downward trend attributed to potential factors such as improved early detection, treatment advancements, and changes in population health behaviors.
Future trends to watch include technological progress in medical treatment and diagnostics, potential shifts in healthcare policy, and changes in public health initiatives that could further impact the incidence and management of such illnesses, impacting discharge rates.
